+1 more ↓
78%
Finnrick rating
#8 of 57 Semaglutide vendors
13 of 16 classifiable tests passed
natural 81%
methodology · Purity focus
Finnrick analysis · Semaglutide

Polaris Peptides semaglutide shows an improving but not spotless purity-focused profile: three early purity misses were followed by clean later results. Check the +31% overfill and several no-batch-ID passes when judging consistency.

methodology →
vendor intelligence report
Vendor Intelligence Report: Polaris Peptides

We investigated who actually operates Polaris Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

28 pages8 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$9.45
85%
15
2
GHK-Cu
$0.54
81%
4
3
Semaglutideselected
$9.78
78%
17
4
Retatrutide
$11.90
78%
29
5
Mazdutide
$15.00
74%
3
6
PT-141
$3.40
64%
8
7
Survodutide
$12.75
53%
6
8
BPC-157
$5.95
35%
13
9
CJC-1295
$5.40
32%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%13 Feb 2025: 57%13 Feb 2025: 51%14 Feb 2025: 60%14 Feb 2025: 62%14 Feb 2025: 64%14 Feb 2025: 66%19 Feb 2025: 70%19 Feb 2025: 72%25 Apr 2025: 72%29 Apr 2025: 74%29 Apr 2025: 75%6 May 2025: 77%11 Aug 2025: 76%12 Aug 2025: 78%12 Aug 2025: 79%25 Jul 2026: current 78%57%76%78%Feb 25Jul 26
Showing Semaglutide tests only
Polaris Peptides Semaglutide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
12 Aug 2025Pass
Tested
lab nameView COA
12 Aug 2025Pass
Tested
lab nameView COA
11 Aug 2025Pass
Tested
lab nameView COA
6 Aug 2025Incomplete
Tested
lab nameView COA
6 May 2025Pass
Tested
lab nameView COA
29 Apr 2025Pass
Tested
lab nameView COA
29 Apr 2025Pass
Tested
lab nameView COA
25 Apr 2025Pass
Tested
lab nameView COA
19 Feb 2025Pass
Tested
lab nameView COA
19 Feb 2025Pass
Tested
lab nameView COA
1-10 of 17

About Polaris Peptides test results from Finnrick

Polaris Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 99 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Polaris Peptides peptides in this dataset are Semaglutide (17 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 99 recent tests.

Corrections
No corrections.